Salt Lake City-based Spectrum Solutions and its medical device and services division, Spectrum DNA, have partnered with Previon, an at-home patient medical testing kit manufacturer headquartered in Yorba Linda, California, to produce a do-it-yourself version of Spectrum’s saliva COVID-19 testing system. Spectrum’s saliva collection kit for COVID-19 testing was the first such product to receive U.S. Food and Drug Administration emergency use authorization (EUA). Previon said it began shipping the kits earlier this month.
“Getting tests to essential workers who may need to be tested often is vital, as COVID-19 continues to surge,” said Joel Luce, CEO of Previon. “Our partnership with Spectrum Solutions makes Previon the only company with an ‘under-one-roof’ capability to manage large-scale, at-home test fulfillment, from design to production for COVID-19 and other conditions.”
Previon custom-engineered and manufactured packaging for the use of Spectrum’s SDNA-1000 saliva collection kits. Kits include tailored patient letters, along with instructions to return the kit to the specified labs. Spectrum’s series of FDA EUA authorizations have created a direct path for certified laboratories wanting to offer saliva-based COVID-19 testing by using Spectrum’s right-of-reference data and a laboratory developed test, Previon said.
“Testing is the purposeful pursuit of knowledge and understanding, a window providing visibility into the disease,” said Leslie Titus Bryant, spokesperson for Spectrum Solutions. “This partnership with Previon delivers the at-home saliva-based testing option medical groups have been requesting to not only mitigate unnecessary in-clinic viral exposure but provide patients a quicker path to informed decisions and treatment.”
